Wir sind mit live! Mehr erfahren
ELV-Symbol

Elevance Health

428,26 USD
-0,17
0,04 %
Zum Börsenschluss Aktualisiert 16. Okt., 16:00 EDT
Vor Börsenbeginn
Nachbörslich
426,44
-1,82
0,42 %
1 Tag
-0,04 %
5 Tage
3,2 %
1 Monat
3,81 %
3 Monate
14,86 %
6 Monate
35,6 %
Seit Jahresbeginn
20,89 %
1 Jahr
23 %
5 Jahre
10,32 %
10 Jahre
262,07 %
 

Profil: Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 45 million medical members at the end of 2025. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states in government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.

Mitarbeiter: 97.100

Nachrichten

Positiv
Neutral
Negativ
Stimmung 3 Monate
Positiv 38,1 %
Neutral 47,6 %
Negativ 14,3 %
Positiv
Zacks Investment Research
vor 16 Stunden
Unveiling Elevance Health (ELV) Q3 Outlook: Wall Street Estimates for Key Metrics
Besides Wall Street's top-and-bottom-line estimates for Elevance Health (ELV), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2026.
Unveiling Elevance Health (ELV) Q3 Outlook: Wall Street Estimates for Key Metrics
Neutral
Zacks Investment Research
gestern
Elevance Q3 Earnings Preview: Will Lower Premiums Weigh on Results?
Can ELV overcome a 4.9% premium decline and weaker Health Benefits income? Membership losses add pressure, though higher product revenues may offer some relief.
Elevance Q3 Earnings Preview: Will Lower Premiums Weigh on Results?
Positiv
Zacks Investment Research
vor 11 Tagen
ELV or DHR: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the Medical Services sector have probably already heard of Elevance Health (ELV) and Danaher (DHR). But which of these two stocks is more attractive to value investors?
ELV or DHR: Which Is the Better Value Stock Right Now?
Neutral
Business Wire
vor 11 Tagen
Elevance Health to Hold Conference Call and Webcast to Discuss Third Quarter 2026 Results on October 21, 2026
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health (NYSE: ELV) will release third quarter 2026 financial results on October 21, 2026 at 6:00 a.m. Eastern Daylight Time (“EDT”). Management will review these results and its outlook during a conference call at 8:30 a.m. EDT that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers: 888-947-9963 - Access Code - 3972058 (Domestic) 312-470-0178 - Access Code - 3972058 (International) 800-3.
Elevance Health to Hold Conference Call and Webcast to Discuss Third Quarter 2026 Results on October 21, 2026
Negativ
Zacks Investment Research
vor 14 Tagen
Are Medical Stocks Lagging Elevance Health, Inc. (ELV) This Year?
Here is how Elevance Health (ELV) and American Well Corporation (AMWL) have performed compared to their sector so far this year.
Are Medical Stocks Lagging Elevance Health, Inc. (ELV) This Year?
Neutral
Business Wire
vor 15 Tagen
Elevance Health's Affiliated 2027 Medicare Advantage Plans Advance Stability, Choice and More Coordinated Support
INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health (NYSE: ELV) announced today that its affiliated health plans will offer 2027 Medicare Advantage plans designed to help members navigate healthcare more confidently through meaningful choice, simpler benefit experiences and personalized support that reflects individual health needs. As members evaluate Medicare coverage for 2027, many want to understand their benefits, connect to care, manage healthcare costs and know where to turn for support throu.
Elevance Health's Affiliated 2027 Medicare Advantage Plans Advance Stability, Choice and More Coordinated Support
Negativ
Zacks Investment Research
letzten Monat
Are Medical Stocks Lagging Elevance Health, Inc. (ELV) This Year?
Here is how Elevance Health (ELV) and American Well Corporation (AMWL) have performed compared to their sector so far this year.
Are Medical Stocks Lagging Elevance Health, Inc. (ELV) This Year?
Neutral
Seeking Alpha
letzten Monat
Baron Health Care Fund Q2 2026 Portfolio Activity
During the quarter, we added 8 new positions and exited 6 positions, bringing the number of positions in the Fund to 43. We re-established positions in two previously owned managed care companies, UnitedHealth Group Incorporated and Elevance Health, Inc. We established a new position in Sartorius Stedim Biotech S.A., which supplies equipment and reagents to biopharmaceutical companies for the production of biologic drugs.
Baron Health Care Fund Q2 2026 Portfolio Activity
Positiv
Zacks Investment Research
letzten Monat
ELV or DHR: Which Is the Better Value Stock Right Now?
Investors with an interest in Medical Services stocks have likely encountered both Elevance Health (ELV) and Danaher (DHR). But which of these two companies is the best option for those looking for undervalued stocks?
ELV or DHR: Which Is the Better Value Stock Right Now?
Positiv
Benzinga
letzten Monat
Elevance Health Stock is Moving Higher After FY26 EPS Reaffirmation
Elevance Health Inc. (NYSE:ELV) shares are jumping Thursday after the company reaffirmed its full-year 2026 earnings guidance ahead of a series of investor meetings. Here's what you should know.
Elevance Health Stock is Moving Higher After FY26 EPS Reaffirmation
Kursdiagramme mit Lightweight Charts™ umgesetzt